immunization during pregnancy; maternal immunization
Jump to navigation
Jump to search
Indications
- influenza virus vaccine (inactivated)
- acellular pertussis vaccine/diphtheria toxoid/tetanus toxoid (TdaP)
- 3rd trimester TdaP 78% effective & 91% effective at preventing pertussis-related hospitalization[2]
- special circumstances
- anthrax vaccine (travel)
- BCG (travel)
- hepatitis A vaccine (risk factors)
- hepatitis B vaccine (risk factors)
- Japanese encephalitis virus vaccine (risk factors)
- meningococcal conjugate vaccine (risk factors)
- pneumococcal vaccine (PCV13 & PPSV23)*
- poliovirus vaccine inactivated (risk factors)
- rabies vaccine (risk factors)
- smallpox vaccine (exposure)#
- typhoid polysaccharide vaccine*
- yellow fever vaccine (risk factors)$
* insufficient data to assess any benefit
# entire world supply of smallpox in secure facility
$ if benefit exceeds risk; may be exception to rule of contraindication of live virus vaccine during pregnancy[1]
Contraindications
- live virus vaccines
- HPV vaccine (not recommended)[1]
- live attenuated influenza virus vaccine
- measles, mumps & rubella combined vaccine (MMR)
- smallpox vaccine (absence of exposure)
- Herpes zoster vaccine
More general terms
Additional terms
References
- ↑ 1.0 1.1 1.2 Omer SB Maternal Immunization. N Engl J Med 2017; 376:1256-1267. March 30, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28355514 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMra1509044
- ↑ 2.0 2.1 Skoff TH, Blain AE, Watt J et al. Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants < 2 months of age: A case-control evaluation. Clin Infect Dis 2017 Sep 28; PMID: https://www.ncbi.nlm.nih.gov/pubmed/29028938